NATION
Vicki L. Sato, vice president-research, will replace Richard A. Flavell as head of research at Biogen, a biotechnology firm with headquarters in Cambridge, Mass. Sato has also been appointed to the company’s scientific board. Flavell has been appointed chairman of the section of immunobiology at Yale University and investigator in the Howard Hughes Medical Institute.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
